On the recordJanuary 8, 2018
Let the record show that when that specific question for Mr. Azar was asked--did he ever lower the price of a Lilly drug sold in the United States, Mr. Azar said 'no.'
Source
congress.govLet the record show that when that specific question for Mr. Azar was asked--did he ever lower the price of a Lilly drug sold in the United States, Mr. Azar said 'no.'
Wyden highlights Azar's admission about drug pricing during a Senate Finance Committee hearing.
Share
More from Ron Wyden
The proposed rule is clear regulatory overreach that would have disastrous impacts for lawfully present immigrants and their families who are legally eligible for refundable tax credits.
The White House should make MITRE’s findings public as soon as possible.
As Congress debates solutions to protect our privacy and civil liberties, the MITRE report could provide important information about how these cameras and other surveillance programs are already impacting Americans’ rights.